L26/P-640 Mitoscore Tracks Embryo Development but Does Not Predict Pregnancy: A Retrospective Analysis of 583 Embryos in IVF-PGT-A Cycles
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von P.S. Divyashree und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does Mitoscore (mitochondrial DNA content) independently predict implantation, clinical pregnancy, or live birth outcomes in euploid embryos undergoing IVF with PGT-A? Summary answer Mitoscore correlates strongly with developmental kinetics but does not independently predict implantation or pregnancy, limiting its clinical utility for selecting among euploid embryos. What is known already Mitochondrial DNA content (Mitoscore) has been proposed as a biomarker reflecting embryo viability and metabolic competence. Prior studies show conflicting results: some report higher mtDNA levels in aneuploid embryos and reduced implantation potential in embryos with elevated mitochondrial load. However, its predictive ability after euploid selection remains unclear. Although mtDNA correlates with blastulation timing and morphology, the extent to which it provides value beyond standard embryological parameters is debated. Robust data assessing whether Mitoscore serves as an independent predictor of clinical outcomes—particularly in euploid transfers—are still limited and inconsistent across studies. Study design, size, duration This was a retrospective cohort study evaluating clinical and embryological data from IVF-PGT-A cycles conducted between January 2020 to December 2025. A total of 135 patients contributed 583 embryos with complete Mitoscore, PGT-A, and outcome data. Of these, 180 euploid embryo transfers were analyzed for implantation, clinical pregnancy, and live birth outcomes. Statistical methods included non-parametric testing, regression analysis, correlation matrices, and ROC evaluation. Participants/materials, setting, methods Inclusion criteria were ICSI-PGT-A cycles with available Mitoscore values and confirmed outcomes. Mitoscore was compared between implanted vs. non-implanted euploid embryos (Mann–Whitney U). Logistic regression controlled for confounders including maternal age. Correlation analyses assessed associations with ovarian stimulation dose and clinical parameters. ROC curves evaluated discriminative ability. Subgroup analyses examined Day-5 vs. Day-6 blastocysts to assess kinetic bias. Main results and the role of chance A total of 583 embryos (266 euploid, 45%) and 180 transfers were analyzed. Implantation rate was 36.3%. Mitoscore differed significantly between Day-5 (mean: 18.14) and Day-6 blastocysts (mean: 26.72; p = 0.0006), confirming strong correlation with developmental speed. However, Mitoscore did not differ significantly between embryos that implanted and those that did not (18.97 vs. 20.03; p = 0.39), and ROC analysis showed no discriminative ability (AUC 0.53). Day-5-only subgroup analysis also showed no association (p = 0.87). No clinical, demographic, or laboratory variables showed meaningful correlation between Mitoscore and pregnancy outcomes. Higher gonadotropin dose demonstrated a modest positive correlation with Mitoscore (r = 0.22, p = 0.017), possibly reflecting metabolic stress in poor responders, though clinically insignificant. Power analysis confirmed the study was adequately powered to detect clinically meaningful effects; the negligible observed effect size (d = 0.13) suggests lack of predictive value is real rather than underpowered. Limitations, reasons for caution Retrospective design, single-centre data, and limited Day-6 transfer numbers may restrict generalisability. Mitoscore variability across platforms is a known limitation. Larger multicentre datasets may better evaluate subtle biological associations which remain statistically irrelevant in clinical decision-making. Wider implications of the findings While biologically informative, Mitoscore does not improve prediction once euploid status and morphology are known. It should not be used as a selection tool among euploid embryos. Embryo prioritization should continue to rely on morphology and developmental kinetics, with Mitoscore serving only as a developmental correlate Trial registration number No
Zitieren
APA
Divyashree, P., Kandari, S., Sathyanarayana, C., Reddy, S., Fathima, S., & Pranesh, G. (2026). L26/P-640 Mitoscore Tracks Embryo Development but Does Not Predict Pregnancy: A Retrospective Analysis of 583 Embryos in IVF-PGT-A Cycles. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.970
Vancouver
Divyashree P, Kandari S, Sathyanarayana C, Reddy S, Fathima S, Pranesh G. L26/P-640 Mitoscore Tracks Embryo Development but Does Not Predict Pregnancy: A Retrospective Analysis of 583 Embryos in IVF-PGT-A Cycles. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.970
BibTeX
@article{Divyashree2026,
author = {Divyashree, P.S. and Kandari, S. and Sathyanarayana, C. and Reddy, S. and Fathima, S. and Pranesh, G.},
title = {L26/P-640 Mitoscore Tracks Embryo Development but Does Not Predict Pregnancy: A Retrospective Analysis of 583 Embryos in IVF-PGT-A Cycles},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.970}
}
EUVIMED